Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2004 3
2005 8
2010 1
2011 7
2012 8
2013 2
2014 8
2015 5
2016 8
2017 8
2018 8
2019 15
2020 12
2021 26
2022 21
2023 16
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Results by year

Filters applied: . Clear all
Page 1
Fibroblast activation protein targeted therapy using [177Lu]FAPI-46 compared with [225Ac]FAPI-46 in a pancreatic cancer model.
Liu Y, Watabe T, Kaneda-Nakashima K, Shirakami Y, Naka S, Ooe K, Toyoshima A, Nagata K, Haberkorn U, Kratochwil C, Shinohara A, Hatazawa J, Giesel F. Liu Y, et al. Among authors: watabe t. Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):871-880. doi: 10.1007/s00259-021-05554-2. Epub 2021 Sep 18. Eur J Nucl Med Mol Imaging. 2022. PMID: 34537893 Free PMC article.
Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models.
Watabe T, Liu Y, Kaneda-Nakashima K, Shirakami Y, Lindner T, Ooe K, Toyoshima A, Nagata K, Shimosegawa E, Haberkorn U, Kratochwil C, Shinohara A, Giesel F, Hatazawa J. Watabe T, et al. J Nucl Med. 2020 Apr;61(4):563-569. doi: 10.2967/jnumed.119.233122. Epub 2019 Oct 4. J Nucl Med. 2020. PMID: 31586001 Free PMC article.
The current status of prostate cancer treatment and PSMA theranostics.
Uemura M, Watabe T, Hoshi S, Tanji R, Yaginuma K, Kojima Y. Uemura M, et al. Among authors: watabe t. Ther Adv Med Oncol. 2023 Jul 3;15:17588359231182293. doi: 10.1177/17588359231182293. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37424944 Free PMC article. Review.
Immuno-PET and Targeted α-Therapy Using Anti-Glypican-1 Antibody Labeled with 89Zr or 211At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma.
Watabe T, Kabayama K, Naka S, Yamamoto R, Kaneda K, Serada S, Ooe K, Toyoshima A, Wang Y, Haba H, Kurimoto K, Kobayashi T, Shimosegawa E, Tomiyama N, Fukase K, Naka T. Watabe T, et al. J Nucl Med. 2023 Dec 1;64(12):1949-1955. doi: 10.2967/jnumed.123.266313. J Nucl Med. 2023. PMID: 37827841 Free PMC article.
Epithelioid granuloma mimicking lung cancer showed intense uptake on [18F]FAPI-74 PET.
Watabe T, David IR, Kimura T, Hiroshima T, Tatsumi M, Naka S, Kamiya T, Fukui E, Kanou T, Ose N, Funaki S, Mori Y, Cardinale J, Kato H, Morii E, Shintani Y, Giesel FL. Watabe T, et al. Eur J Nucl Med Mol Imaging. 2024 Feb;51(3):930-931. doi: 10.1007/s00259-023-06478-9. Epub 2023 Oct 28. Eur J Nucl Med Mol Imaging. 2024. PMID: 37891330 Free PMC article. No abstract available.
Comparison of Nuclear Medicine Therapeutics Targeting PSMA among Alpha-Emitting Nuclides.
Kaneda-Nakashima K, Shirakami Y, Kadonaga Y, Watabe T, Ooe K, Yin X, Haba H, Shirasaki K, Kikunaga H, Tsukada K, Toyoshima A, Cardinale J, Giesel FL, Fukase K. Kaneda-Nakashima K, et al. Among authors: watabe t. Int J Mol Sci. 2024 Jan 11;25(2):933. doi: 10.3390/ijms25020933. Int J Mol Sci. 2024. PMID: 38256007 Free PMC article.
152 results